Total Payments
$8,140
2024 Payments
$577.94
Companies
48
Transactions
352
Medicare Patients
406
Medicare Billing
$86,545
Payment Breakdown by Category
Food & Beverage$6,038 (74.2%)
Travel$2,102 (25.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,038 | 338 | 74.2% |
| Travel and Lodging | $2,102 | 14 | 25.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,565 | 28 | $0 (2024) |
| Relievant Medsystems, Inc. | $1,308 | 9 | $0 (2023) |
| Boston Scientific Corporation | $742.77 | 45 | $0 (2024) |
| PFIZER INC. | $575.93 | 46 | $0 (2021) |
| Medtronic USA, Inc. | $508.19 | 29 | $0 (2020) |
| Nevro Corp. | $471.09 | 14 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $344.73 | 28 | $0 (2021) |
| Amgen Inc. | $257.63 | 13 | $0 (2022) |
| ABBVIE INC. | $240.01 | 13 | $0 (2024) |
| Eisai Inc. | $181.25 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $577.94 | 28 | ABBVIE INC. ($140.42) |
| 2023 | $3,083 | 47 | Medtronic, Inc. ($1,434) |
| 2022 | $396.47 | 22 | Nevro Corp. ($86.98) |
| 2021 | $1,045 | 67 | Eisai Inc. ($158.52) |
| 2020 | $760.74 | 54 | PFIZER INC. ($203.21) |
| 2019 | $784.74 | 49 | Boston Scientific Corporation ($273.49) |
| 2018 | $699.09 | 34 | Nevro Corp. ($195.92) |
| 2017 | $792.26 | 51 | Medtronic USA, Inc. ($265.95) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.44 | General |
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/01/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/01/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/10/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Drug Infusion Systems | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immune | ||||||
| 08/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.92 | General |
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/21/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Immune | ||||||
| 06/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $44.96 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/14/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/28/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Gastroenterology | ||||||
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/28/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $24.74 | General |
| Category: Pain | ||||||
| 02/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 78 | 192 | $40,071 | $15,734 |
| 2022 | 2 | 74 | 170 | $47,225 | $14,711 |
| 2021 | 8 | 148 | 467 | $164,079 | $37,692 |
| 2020 | 5 | 106 | 331 | $81,010 | $18,409 |
Total Patients
406
Total Services
1,160
Medicare Billing
$86,545
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 171 | $33,687 | $13,632 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,384 | $2,101 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 153 | $41,463 | $12,808 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,762 | $1,902 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 199 | $66,790 | $17,468 | 26.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Office | 2021 | 11 | 23 | $34,101 | $7,154 | 21.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves with imaging guidance | Office | 2021 | 11 | 46 | $29,096 | $5,909 | 20.3% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 13 | 23 | $18,436 | $4,312 | 23.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $10,859 | $2,315 | 21.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 19 | 66 | $1,467 | $274.18 | 18.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 13 | 20 | $2,400 | $252.00 | 10.5% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2021 | 19 | 70 | $930.00 | $6.52 | 0.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 165 | $46,607 | $11,615 | 24.9% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Office | 2020 | 14 | 22 | $19,380 | $4,050 | 20.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 21 | 21 | $8,311 | $2,402 | 28.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 20 | 72 | $6,580 | $337.37 | 5.1% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2020 | 17 | 51 | $131.92 | $4.46 | 3.4% |
About Dr. David Byrd, MD
Dr. David Byrd, MD is a Interventional Pain Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720173164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Byrd, MD has received a total of $8,140 in payments from pharmaceutical and medical device companies, with $577.94 received in 2024. These payments were reported across 352 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,038).
As a Medicare-enrolled provider, Byrd has provided services to 406 Medicare beneficiaries, totaling 1,160 services with total Medicare billing of $86,545. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Salt Lake City, UT
- Active Since 10/03/2006
- Last Updated 06/12/2008
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720173164
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $1,505
- Intracept (Device) $1,333
- XTAMPZA (Drug) $344.73
- Senza Spinal Cord Stimulation System (Device) $326.89
- KYPHON Balloon Kyphoplasty (Device) $306.64
- SPECTRA WAVEWRITER (Device) $247.70
- LYRICA (Drug) $247.59
- Aimovig (Biological) $216.25
- UBRELVY (Drug) $196.46
- Dayvigo (Drug) $181.25
- Nucynta (Drug) $129.60
- BOTOX (Biological) $126.64
- Omnia (Device) $120.75
- EUCRISA (Drug) $119.90
- AJOVY (Biological) $116.29
- COLOGUARD DNA CAPTURE REAGENTS (Device) $102.78
- Nalu Neurostimulation System (Device) $99.07
- BELBUCA (Drug) $98.40
- PROCLAIM (Device) $91.19
- Movantik (Drug) $90.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.